Promotion of corneal stroma wound healing with human epidermal growth factor prepared from recombinant DNA
US4959353A · kind A · utility
30Cited by
3References
21Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 23, 1987 |
| Grant date | Sep 25, 1990 |
| Priority date | — |
| Expiry date | Apr 23, 2007 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating corneal stromal wounds to promote regeneration of the affected tissue is provided. This method employs recombinant human epidermal growth factor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.